BLC FAQ’s

BLC consultants are seasoned professionals who were laboratory specialists before the Clinical Laboratory Improvement Act of 1988 (CLIA) instituted by Congress. BLC can set up your lab from design to implementation.

CLIA is a federal program enforced by the states and reports directly to Centers for Medicare and Medicaid Services (CMS). COLA is a private organization with authority by CMS to enforce CLIA regulations. BLC works with labs individually to determine which accreditation is best.

Yes, with the right insurance mix and specimen volume, an in-house lab will be profitable. BLC performs a free analysis to see if an investment in an in-house laboratory is going to be profitable.

BLC does not endorse any PT company. However, American Proficiency Institute (API) and American Association of Bio Analysts (AAB) are most popular with physician office labs (POLs) and small reference labs. College of American Pathologists (CAP) specializes in large laboratories, such as reference labs and hospitals.

BLC has experience building small POLs and large reference labs. All labs must follow the same guidelines.

95% of all labs are moderately complex and include most tests such as chemistry, auto CBC and thyroids, etc.  A highly complex lab requires personnel to perform more complicated and labor-intensive tests, such as enzyme-linked immuno assay and a highly complex lab also includes toxicology and other lab-developed tests (LDTs).

Yes. Proper ICD-10 coding and knowledge of how frequently tests can be performed is imperative. The dollar amounts vary by state.

In-house labs offer superior quality to outside labs because 1) specimen transport to the reference lab can lead to erroneous results and 2) large laboratories have been known to lose specimens and call the result Quantity Not Sufficient (QNS).

Not if you employ knowledgeable lab personnel and hire a company like BLC.

BLC consultants can and will help you keep your license and prevent future problems from occurring in your lab.